Although CD4+ TILs are observed in CRC [59,80,87], the density of this subInt. population has shown little prognostic value in CRC to date, and is not significantly different in primary tumours of patients with metastatic or non-metastatic disease [59]. This evidence concerns the gene CD4 and colorectal carcinoma.